26/11/2014 05:29:21 Cookie Policy Free Membership Login

NASDAQ Market News

Apple Proving Sir Isaac Newton Wrong

25 Nov 2014 @ 21:31
Who knew that when Sir Isaac contemplated the Apple falling that he would be a candidate for Worst Stock Market Analyst. If he were alive today, he might surprised to see Apple’s going up. Whereas the infamous apple upon which he based his observation bonked him on the head, the Apple (NASDAQ:AAPL) of today would leave him bonkers. Yesterday, 24 November, Apple closed at a record high of...

Class action lawsuit filed against MOL Global

24 Nov 2014 @ 22:19
Action “seeks to recover damages against Defendants for alleged violations of the federal securities laws” Pomerantz LLP has filed a class action lawsuit against MOL Global (Nasdaq:MOLG) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 14-cv-09357, is on behalf of a class consisting of all...

Leipurin to start listing on the NASDAQ?

23 Nov 2014 @ 22:12
LEIPURIN PLC APPLIES FOR LISTING ON THE NASDAQ OMX HELSINKI LTD The Board of Directors of Leipurin, and the Board of Directors of its sole shareholder Aspo, have decided on 19 November 2014 to apply for listing of the shares in Leipurin on the Official List of NASDAQ OMX Helsinki Ltd as previously announced. Leipurin and Aspo will separately announce about the share issue and the share sale...

Consumer Favorite Habit Stuns with IPO

21 Nov 2014 @ 20:49
America’s favorite food – the hamburger – has a new favorite brand that also has a highly successful IPO. A Consumer Reports survey in July 2014 named Habit Burgers the best in the nation. Most Americans responded, “Who?” Today, a growing number of Americans know who Habit (NASDAQ:HABT) is, especially some very happy investors. All they want to know now is when is...

Intel Offers Insight Into What's In Sight

20 Nov 2014 @ 22:59
The share price of Intel (NASDAQ:INTC) rose steadily this morning, then spiked upward as the news reported by the board of directors at the company’s annual shareholder’s meeting became public. Opening this morning at 34.15, shares gained to 4.66% to close the day at 35.95, the highest the Intel share price has closed since February 2001. Two tidbits essentially prompted the uptick...

Williams Sonoma Climbs After Closing Bell

19 Nov 2014 @ 22:50
Williams Sonoma (NYSE:WSM) is one of the United States’ largest e-commerce retailers, serving customers worldwide. Its upscale brick and mortar stores located in the U.S., Canada, Puerto Rico, Australia and the UK are supplemented by franchised branding in several Middle Eastern countries and the Philippines. The company issued its third quarter results shortly after the New York Stock...

Virgin America Stock – a Promising Market

18 Nov 2014 @ 23:12
Virgin America stock (NASDAQ:VA) is a promising market which may make substantial gains within the next several months. The price may go upwards consistently irrespective of pullbacks that are expected occasionally. A pullback is a normal part of market movements. It is not a bane – it is rather a blessing to skilled traders. Significant rallies are followed by serious pullbacks. When a price...

BP lay out $200m Belgian upgrade plan

18 Nov 2014 @ 22:51
Lucky Belgium. BP announced today that it plans to invest over $200 million to upgrade its purified terephthalic acid (PTA) plants at Cooper River, South Carolina and Geel, Belgium. The investments will position these assets amongst the most efficient PTA manufacturing facilities in the world. “This allows us to apply our latest proprietary technology and process know-how to existing...

Virgin America IPO Takes Off

14 Nov 2014 @ 22:20
The Virgin America IPO (NASDAQ:VA) took off at $23.00 late yesterday, right down the middle of the runway that had been defined as being $21.00 to $24.00 wide. When it went public at 10:02 a.m. it had reached an altitude of $27.00 before ascending to $31.19 and cruising home at $30.00. VA’s share price is continuing to fly along at $30.26 in after hours trading. The company sold 231,210...

Conatus Pharmaceuticals reports increased net losses

12 Nov 2014 @ 23:05
Larger losses than 2013 Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial results for the quarter and nine months ended September 30, 2014, and provided updates on its clinical development programs. Financial Results: The net loss for the third quarter of 2014...
  • Jump to a different page:
  • 1
  • 2
  • 3
  • ...
  • 47
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 141126 05:29